Relying heavily on testimony provided during the sworn depositions of Sean LaNeve, Chris Girsch, and Charles Girsch, as well as corporate representatives of RTI and Avalign, Omnia gave a glimpse into some of the many facts and arguments it intends to use during trial, which is currently set for October 7, 2024.

Omnia Medical, a medical device company committed to providing the industry with innovative solutions utilizing proven techniques, announced that the Patent Trial and Appeal Board (PTAB) of the US Patent and Trademark Office on Thursday September 20th granted institution in IPR2023-00625.

Omnia Medical, a medical device company committed to providing the industry with innovative solutions utilizing proven techniques, announced that a trial date has been set for October 2024 in its ongoing lawsuit with PainTEQ.

SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) sensing technology to secure and streamline the placement of bone implants, and Omnia Medical, a medical device company focused on innovative solutions utilizing proven techniques, announced today the signature of a co-development and exclusive distribution agreement for adult spine surgery in the United States.

US FDA 510(k) clearance paves the way for an innovative orthopedic product that offers the potential to improve bone apposition and, as a consequence, patient outcomes. ^1-3